These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23808747)

  • 41. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
    Jeunemaitre X; Charru A; Pascoe L; Guyene TT; Aupetit-Faisant B; Shackleton CH; Schambelan M; Plouin PF; Corvol P
    Presse Med; 1995 Sep; 24(27):1243-8. PubMed ID: 7501605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary aldosteronism and aldosterone-associated hypertension.
    Rayner B
    J Clin Pathol; 2008 Jul; 61(7):825-31. PubMed ID: 18587013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of aldosterone in hypertension].
    Vonend O; Quack I; Rump LC
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):65-74. PubMed ID: 20213371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
    Piaditis G; Markou A; Papanastasiou L; Androulakis II; Kaltsas G
    Eur J Endocrinol; 2015 May; 172(5):R191-203. PubMed ID: 25538205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mineralocorticoid hypertension. A new form of secondary hypertension?].
    Román O
    Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Update on endocrine hypertension].
    Al-Salameh A; Cohen R; Chanson P; Plouin PF
    Ann Endocrinol (Paris); 2012 Oct; 73 Suppl 1():S26-35. PubMed ID: 23089379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA; Beuschlein F; Vonend O
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Primary hyperaldosteronism: indications for screening].
    Chikhladze NM
    Ter Arkh; 2022 Jan; 94(1):107-113. PubMed ID: 36286925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aldosterone biosynthesis in the human adrenal cortex and associated disorders.
    Nakamura Y; Yamazaki Y; Konosu-Fukaya S; Ise K; Satoh F; Sasano H
    J Steroid Biochem Mol Biol; 2015 Sep; 153():57-62. PubMed ID: 26051166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Viola A; Tizzani D; Iannaccone A; Crudo V; Burrello J; Milan A; Rabbia F; Veglio F
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4826-33. PubMed ID: 24057288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary hyperaldosteronism].
    van den Meiracker AH; Deinum J
    Ned Tijdschr Geneeskd; 2003 Aug; 147(33):1580-5. PubMed ID: 12951726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of primary hyperaldosteronism. Case report].
    Bulfoni A; Gobbato F
    Arch Sci Med (Torino); 1979; 136(4):643-52. PubMed ID: 550763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Primary aldosteronism is an underdiagnosed cause of hypertension. Important to find undiagnosed patients--effective treatment available].
    Ragnarsson O; Muth A; Johannsson G; Wängberg B
    Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aldosterone and Cardiovascular Disease. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2009 Feb; 34(2):49. PubMed ID: 19135615
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.